title: Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors.
abstract: We have created a novel cellular vehicle for gene therapy of malignant gliomas by transfection of murine bone marrow stroma cells (MSCs) with a cDNA encoding epidermal growth factor receptor (EGFR). These cells (EGFR-MSCs) demonstrate enhanced migratory responses toward glioma-conditioned media in comparison to primary MSCs in vitro. Enhanced migration of EGFR-MSC was at least partially dependent on EGF-EGFR, PI3-, MAP kinase kinase, and MAP kinases, protein kinase C, and actin polymerization. Unlike primary MSCs, EGFR-MSCs were resistant to FasL-mediated cytotoxicity and were capable of stimulating allogeneic mixed lymphocyte reaction, suggesting EGFR-MSCs possess suitable characteristics as vehicles for brain tumor immuno-gene therapy. Following injection at various sites, including the contralateral hemisphere in the brain of syngeneic mice, EGFR-MSCs were able to migrate toward GL261 gliomas or B16 melanoma in vivo. Finally, intratumoral injection with EGFR-MSC adenovirally engineered to secrete interferon-alpha to intracranial GL261 resulted in significantly prolonged survival in comparison to controls. These data indicate that EGFR-MSCs may serve as attractive vehicles for infiltrating brain malignancies such as malignant gliomas.
authors.affiliation: Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213-1863, USA.
authors.forename: Hidemitsu
authors.initials: H
authors.lastname: Sato
authors.forename: Naruo
authors.initials: N
authors.lastname: Kuwashima
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Sakaida
authors.forename: Manabu
authors.initials: M
authors.lastname: Hatano
authors.forename: Jill E
authors.initials: JE
authors.lastname: Dusak
authors.forename: Wendy K
authors.initials: WK
authors.lastname: Fellows-Mayle
authors.forename: Glenn D
authors.initials: GD
authors.lastname: Papworth
authors.forename: Simon C
authors.initials: SC
authors.lastname: Watkins
authors.forename: Andrea
authors.initials: A
authors.lastname: Gambotto
authors.forename: Ian F
authors.initials: IF
authors.lastname: Pollack
authors.forename: Hideho
authors.initials: H
authors.lastname: Okada
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology / Q000502:physiology*; D001932:Brain Neoplasms / Q000628:therapy*; D002460:Cell Line; D002465:Cell Movement; D004815:Epidermal Growth Factor / Q000378:metabolism; D066246:ErbB Receptors / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D005910:Glioma / Q000628:therapy*; D051379:Mice; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism; D017154:Stromal Cells / Q000502:physiology; D014162:Transfection
chemical_list: D000199:Actins; D004815:Epidermal Growth Factor; D019869:Phosphatidylinositol 3-Kinases; D066246:ErbB Receptors; D011493:Protein Kinase C